Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification

EBioMedicine(2022)10.1016/j.ebiom.2022.104373Source: DataRank Database

Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification is a research paper published in EBioMedicine (2022). On theSindex it has a DataRank of 0. It has been cited 39 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access39 citations

Download PDF

Cite:

Linked data & code

geo nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 6.13)OA: goldTopics (111)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (43)

Matthew J. Cecchini ORCID,John W. Barrett ORCID,Matthew Shammas‐Toma ORCID,Loris De Cecco ORCID,Mara Serena Serafini ORCID

Live enrichment

PubMed:36442320 PMC:PMC9706534 OpenAlex:https://openalex.org/W4310370069

National Cancer Institute

Grant: P30CA016042

National Cancer Institute

Grant: 689715

Big Data and models for personalized Head and Neck Cancer Decision support

Canadian Institutes of Health Research

Grant: PJT-173496

Canadian Institutes of Health Research

Grant: 23573

Canadian Institutes of Health Research

Grant: MOP340674

NIDCR NIH HHS

Grant: R01 DE026471

National Institutes of Health

Grant: 5P50DE030707-02

Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer

National Institutes of Health

Grant: 3P30CA016042-35S3

Cancer Center Support Grant

Canadian Institutes of Health Research

Grant: unidentified

unidentified

Associazione Italiana per la Ricerca sul Cancro

National Institute of Dental and Craniofacial Research

Airc Italian Foundation for Cancer Research

National Institutes of Health

Physicians' Services Incorporated Foundation

FWCI

6.13

Citation Percentile

1.0%

Influential Citations

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.thelancet.com/article/S2352396422005552/pdf

GOLDhttp://www.thelancet.com/article/S2352396422005552/pdf

publisherhttp://www.thelancet.com/article/S2352396422005552/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352396422005552?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352396422005552?httpAccept=text/plain

Fields of Study

Head and Neck Cancer StudiesInflammatory Biomarkers in Disease PrognosisSalivary Gland Disorders and FunctionsMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciencesHumansPapillomavirus InfectionsRetrospective StudiesNeoplasm Recurrence, LocalOropharyngeal NeoplasmsSquamous Cell Carcinoma of Head and NeckPrognosisBiomarkersHuman Papillomavirus VirusesHead and Neck NeoplasmsPapillomaviridae

MeSH Terms

Squamous Cell Carcinoma of Head and NeckHuman Papillomavirus VirusesHead and Neck NeoplasmsHumansNeoplasm Recurrence, LocalOropharyngeal NeoplasmsPrognosisRetrospective StudiesBiomarkersPapillomaviridaePapillomavirus Infections

Keywords

BiomarkerImmune systemCancerMedicineImmunologyOncologyBiologyInternal medicineGeneticsBiomarkersHPVHead And Neck Squamous Cell CarcinomaTranscriptomicsCancer ImmunologyDe-escalationPrevention (rcdc)POSITIVE HEAD1117 Public Health and Health Services (for)EpidemiologyHuman Papillomavirus Viruses (mesh)Radiation Oncology (rcdc)Head and Neck Neoplasms (mesh)CHEMORADIATIONNECK-CANCERPrecision Medicine (rcdc)1103 Clinical Sciences (for)Precision Medicine32 Biomedical and Clinical Sciences (for-2020)PREDICTORSPapillomaviridaeCancer (rcdc)Humans (mesh)3 Good Health and Well Being (sdg)ArticlesPrognosisBiomarkers (mesh)Oropharyngeal NeoplasmsInfectious DiseasesLocalHead and Neck NeoplasmsPublic Health and Health ServicesSURVIVALPapillomaviridae (mesh)SQUAMOUS-CELL CARCINOMADigestive Diseases (rcdc)EXPRESSIONRetrospective Studies (mesh)Oncology and CarcinogenesisClinical Sciences610Papillomavirus Infections (mesh)HumansDental/Oral and Craniofacial Disease3204 Immunology (for-2020)Retrospective StudiesOropharyngeal Neoplasms (mesh)Biomedical and Clinical SciencesSquamous Cell Carcinoma of Head and NeckPreventionCONCURRENTHUMAN-PAPILLOMAVIRUSPapillomavirus InfectionsBiomarkers; Cancer immunology; De-escalation; HPV; Head and neck squamous cell carcinoma; TranscriptomicsHuman Papillomavirus VirusesCancer (hrcs-hc)3202 Clinical sciences (for-2020)Dental/Oral and Craniofacial Disease (rcdc)Prognosis (mesh)Biomarkers; Cancer immunology; De-escalation; Head and neck squamous cell carcinoma; HPV; Transcriptomics;Good Health and Well Being3211 Oncology and Carcinogenesis (for-2020)Neoplasm RecurrenceInfectious Diseases (rcdc)Squamous Cell Carcinoma of Head and Neck (mesh)4202 Epidemiology (for-2020)Radiation OncologyLocal (mesh)Sexually Transmitted InfectionsNeoplasm Recurrence, LocalDigestive DiseasesSexually Transmitted Infections (rcdc)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification

FAIR Checklist

Authors (43)

Funding (14 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)